187 related articles for article (PubMed ID: 6749881)
1. Characterization of somatomedin binding in human serum by ultracentrifugation and gel filtration.
Daughaday WH; Ward AP; Goldberg AC; Trivedi B; Kapadia M
J Clin Endocrinol Metab; 1982 Nov; 55(5):916-21. PubMed ID: 6749881
[TBL] [Abstract][Full Text] [Related]
2. The insulin-like growth factor II/mannose-6-phosphate receptor is present in monkey serum.
Gelato MC; Kiess W; Lee L; Malozowski S; Rechler MM; Nissley P
J Clin Endocrinol Metab; 1988 Oct; 67(4):669-75. PubMed ID: 2971079
[TBL] [Abstract][Full Text] [Related]
3. Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uremic serum.
Powell DR; Rosenfeld RG; Baker BK; Liu F; Hintz RL
J Clin Endocrinol Metab; 1986 Nov; 63(5):1186-92. PubMed ID: 3760118
[TBL] [Abstract][Full Text] [Related]
4. The insulin-like growth factor II/mannose-6-phosphate receptor is present in fetal and maternal sheep serum.
Gelato MC; Rutherford C; Stark RI; Daniel SS
Endocrinology; 1989 Jun; 124(6):2935-43. PubMed ID: 2542005
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the high molecular weight insulin-like growth factor complex in term pregnancy serum.
Liu F; Baxter RC; Hintz RL
J Clin Endocrinol Metab; 1992 Nov; 75(5):1261-7. PubMed ID: 1385469
[TBL] [Abstract][Full Text] [Related]
6. Release of insulin-like growth factors and binding protein activity into serum-free medium of cultured human fibroblasts.
Adams SO; Kapadia M; Mills B; Daughaday WH
Endocrinology; 1984 Aug; 115(2):520-6. PubMed ID: 6378592
[TBL] [Abstract][Full Text] [Related]
7. Preferential measurement of insulin-like growth factor (IGF) I-related peptides in serum with the aid of IGF-binding proteins (IGF BPs) produced by rat liver in culture. Estimation of serum IGF BP levels.
Binoux M; Seurin D; Lassarre C; Gourmelen M
J Clin Endocrinol Metab; 1984 Sep; 59(3):453-62. PubMed ID: 6205015
[TBL] [Abstract][Full Text] [Related]
8. Measurement of somatomedin-related peptides in fetal, neonatal, and maternal rat serum by insulin-like growth factor (IGF) I radioimmunoassay, IGF-II radioreceptor assay (RRA), and multiplication-stimulating activity RRA after acid-ethanol extraction.
Daughaday WH; Parker KA; Borowsky S; Trivedi B; Kapadia M
Endocrinology; 1982 Feb; 110(2):575-81. PubMed ID: 7035142
[TBL] [Abstract][Full Text] [Related]
9. Failure of acid-ethanol treatment to prevent interference by binding proteins in radioligand assays for the insulin-like growth factors.
Mesiano S; Young IR; Browne CA; Thorburn GD
J Endocrinol; 1988 Dec; 119(3):453-60. PubMed ID: 2464662
[TBL] [Abstract][Full Text] [Related]
10. Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: comparison with acid-ethanol treatment and C18 Sep-Pak separation.
Mohan S; Baylink DJ
J Clin Endocrinol Metab; 1995 Feb; 80(2):637-47. PubMed ID: 7531716
[TBL] [Abstract][Full Text] [Related]
11. Purification and characterization of a fetal somatomedin from the sheep: similarity to insulin-like growth factor II.
Hey AW; Browne CA; Thorburn GD
Endocrinology; 1988 Jan; 122(1):12-21. PubMed ID: 3335201
[TBL] [Abstract][Full Text] [Related]
12. Isolation of a somatomedin-binding protein from preterm amniotic fluid. Development of a radioimmunoassay.
Drop SL; Kortleve DJ; Guyda HJ
J Clin Endocrinol Metab; 1984 Nov; 59(5):899-907. PubMed ID: 6207199
[TBL] [Abstract][Full Text] [Related]
13. Specific assay for insulin-like growth factor (IGF) II using the IGF binding proteins extracted from human cerebrospinal fluid.
Binoux M; Lassarre C; Gourmelen M
J Clin Endocrinol Metab; 1986 Nov; 63(5):1151-5. PubMed ID: 2428824
[TBL] [Abstract][Full Text] [Related]
14. Somatomedin inhibitor in uremia.
Phillips LS; Fusco AC; Unterman TG; del Greco F
J Clin Endocrinol Metab; 1984 Oct; 59(4):764-72. PubMed ID: 6384255
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic conversion of insulin-like growth factors to an acidic form(s).
Kuffer AD; Herington AC
Biochem J; 1984 Oct; 223(1):97-103. PubMed ID: 6388567
[TBL] [Abstract][Full Text] [Related]
16. Structure, specificity, and regulation of the insulin-like growth factor-binding proteins in adult rat serum.
Yang YW; Wang JF; Orlowski CC; Nissley SP; Rechler MM
Endocrinology; 1989 Sep; 125(3):1540-55. PubMed ID: 2547590
[TBL] [Abstract][Full Text] [Related]
17. The effect of different isolation procedures on the yields of insulin-like growth factors from human plasma.
Cornell HJ
Prep Biochem; 1982; 12(1):57-76. PubMed ID: 7048285
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-I (IGF-I) concentration in 150-kilodalton complexes containing human IGF-binding protein-3 (hIGFBP-3) after intravenous injection of adult rats with hIGFBP-3.
Lee CY; Wu HB; Suh DS; Rechler MM
Endocrinology; 1997 Apr; 138(4):1649-57. PubMed ID: 9075727
[TBL] [Abstract][Full Text] [Related]
19. Development of valid methods to measure insulin-like growth factors-I and -II in bone cell-conditioned medium.
Mohan S; Bautista CM; Herring SJ; Linkhart TA; Baylink DJ
Endocrinology; 1990 May; 126(5):2534-42. PubMed ID: 1691698
[TBL] [Abstract][Full Text] [Related]
20. Further characterization of growth hormone-dependent somatomedin-binding proteins in rat serum and demonstration of somatomedin-binding proteins produced by rat liver cells in culture.
Moses AC; Nissley SP; Passamani J; White RM
Endocrinology; 1979 Feb; 104(2):536-46. PubMed ID: 446374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
